New headquarters in Scotland strengthens drug discovery research
A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
List view / Grid view
A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
A report published has identified the prospects of immunotherapy treatments...
Scientists have made progress in the development of products that improve mitochondrial function...
Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
The European Research Council has announced its 2018 grant competitions with a total budget of around €1.86bn...
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
A protein has been identified as a possible cause for the adverse reaction of the immune system in patients suffering from lupus.
Topics range from planet formation and male infertility to market analysis for agricultural land and total of around €19 million for first funding period…
A study led has found that the model for the spread of carcinoma - from the primary tumour, to nearby lymph nodes, to other organs - may not apply in all cases.
Scientists have discovered a link between a major mechanism of antibiotic resistance and resistance to the common disinfectant triclosan...
For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.
30 June 2017 | By PerkinElmer
In this webinar, PerkinElmer and AMRI will present a case study wherein high-performance computing (HPC) was leveraged for enhanced performance in image and data analysis of High Content Screening experiments...
The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.
Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukaemia that outperforms standard chemotherapies.